Suppliers / Yangzhou Aurisco Pharmaceutical

Yangzhou Aurisco Pharmaceutical

China 1 employees Updated 9 July 2026

Yangzhou Aurisco Pharmaceutical is an API manufacturer based in China. It holds 18 active US drug master files and 2 valid CEPs across a filed portfolio of 16 molecules.

18
active US DMFs
2
valid CEPs
2
registered plants 1 with an FDA FEI number
1
filings across 1 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Sources: FDA Establishment Registration, read 4 May 2026.

Registered plants

Site FDA FEI
Yangzhou City, China Not on file
China, China 3021695089

What they file, and where

Molecule Regulators Docs
Medroxyprogesterone Acetate SFDA (Saudi Arabia), US FDA 4
Bempedoic Acid SFDA (Saudi Arabia), US FDA 3
Brivaracetam EDQM, US FDA 3
Semaglutide US FDA 2
Clascoterone US FDA 1
Dydrogesterone EDQM 1
Elagolix US FDA 1
Estetrol US FDA 1
Estradiol US FDA 1
Inclisiran US FDA 1
Show all 16 molecules on file
Nusinersen US FDA 1
Rimegepant US FDA 1
Tenofovir Disoproxil US FDA 1
Tirzepatide US FDA 1
Vibegron US FDA 1
Vutrisiran US FDA 1

Also appears on these molecule pages

Bempedoic Acid API Brivaracetam API Elagolix API Estetrol API Estradiol API Medroxyprogesterone API Nusinersen API Rimegepant API Tirzepatide API Vibegron API Semaglutide API Tenofovir Disoproxil API

Filings and GMP by regulator

Regulator Filings GMP certificates
JFDA (JO) 1 None

Questions about Yangzhou Aurisco Pharmaceutical

Does Yangzhou Aurisco Pharmaceutical hold a US DMF or a CEP?
Yangzhou Aurisco Pharmaceutical holds 18 active US drug master files and 2 valid CEPs. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
Is Yangzhou Aurisco Pharmaceutical FDA-registered?
One site operated by Yangzhou Aurisco Pharmaceutical carries an FDA establishment identifier (FEI), which means it is registered with the FDA as a drug establishment. Registration is not the same as approval or inspection clearance.
Where does Yangzhou Aurisco Pharmaceutical manufacture?
2 registered sites are on record, in China (Yangzhou City and China). Every site is listed on this page with the register it came from.
What does Yangzhou Aurisco Pharmaceutical make?
16 molecules are on record against Yangzhou Aurisco Pharmaceutical, including Medroxyprogesterone Acetate, Bempedoic Acid, Brivaracetam and Semaglutide. Each links through to that molecule's full manufacturer list.
Where does Yangzhou Aurisco Pharmaceutical file?
Filings are on record with JFDA (JO), 1 in total.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Yangzhou Aurisco Pharmaceutical comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Comparable suppliers

Changzhou Pharmaceutical Factory shares 4 molecules Apitoria Pharma shares 3 molecules Dr Reddy's Laboratories shares 3 molecules Alivus Life Sciences shares 3 molecules Lupin shares 3 molecules

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability